NA

Navasota Resources Inc.

NAV · V · Healthcare / Drug Manufacturers - Specialty & Generic

0.005CAD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.005
Open0.005
Day Range0.005 – 0.005
52-Week Range0.005 – 0.01
Volume1.00K
Market Cap285.35K
P/E (TTM)0.00
Forward P/E0.00
EPS-0.03
Dividend Yield0.00%
Beta2.20
50-Day Avg0.005
200-Day Avg0.0065

About

NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives industries to combat microorganisms. NAVCO Pharmaceuticals Inc. is headquartered in Vancouver, Canada.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Geoffrey Lee
  • Employees0
  • Headquarters1170 ? 1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1, Canada
  • Websitehttps://navcopharma.com

Leadership

  • Mr. Geoffrey LeeChief Executive Officer
  • Mr. Christopher R. CooperChief Financial Officer · b. 1971
  • Mr. Marek JasinskiCOO & Director · b. 1977
  • Mr. Thomas JusdanisCorporate Secretary & Independent Director · b. 1958

Financials

Income Statement

Currency: CAD2021-09-302022-09-30
Total Revenue00
Operating Income-79.54K-100.09K
EBITDA--100.09K
Net Income-74.08K-93.68K

Balance Sheet

Currency: CAD2021-09-302022-09-30
Total Assets116.03K112.17K
Total Liabilities18.88K108.70K
Total Equity97.15K3.47K
Cash12.07K1.80K

Cash Flow

Currency: CAD2021-09-302022-09-30
Operating Cash Flow-80.71K-10.27K
Financing Cash Flow-88.50K0
Capital Expenditure00
Free Cash Flow-80.71K-10.27K
FCF to OCF100.00%100.00%

Earnings

Report DateJan 28, 2027
EPS Estimate-
EPS Actual-
Surprise-
TimingAfter-hours

Key Statistics & Ratios

Market Cap285.35K
Enterprise Value285.35K
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales2.47
Price / Book0.00
EPS-0.03
Book Value-0.017
Revenue (TTM)5.20K
Gross Profit (TTM)58.73K
EBITDA-19.22K
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets-741.21%
Shares Outstanding57.07M
Shares Float51.08M
Beta2.20
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%